Man Group plc Purchases New Position in National HealthCare Corporation $NHC

Man Group plc acquired a new position in National HealthCare Corporation (NYSEAMERICAN:NHCFree Report) during the 2nd quarter, HoldingsChannel reports. The fund acquired 9,276 shares of the company’s stock, valued at approximately $1,961,000.

Other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in National HealthCare during the third quarter valued at $25,000. Allworth Financial LP acquired a new position in shares of National HealthCare in the second quarter worth about $27,000. Quarry LP boosted its stake in shares of National HealthCare by 171.9% during the 3rd quarter. Quarry LP now owns 261 shares of the company’s stock worth $32,000 after acquiring an additional 165 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of National HealthCare during the 2nd quarter worth about $37,000. Finally, Kestra Advisory Services LLC purchased a new stake in shares of National HealthCare during the 4th quarter worth about $42,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

National HealthCare Trading Up 1.1%

NYSEAMERICAN:NHC opened at $218.97 on Wednesday. The company has a market cap of $3.43 billion, a P/E ratio of 24.63 and a beta of 0.62. National HealthCare Corporation has a twelve month low of $111.24 and a twelve month high of $239.29. The company’s 50-day moving average price is $220.05 and its 200-day moving average price is $190.81.

National HealthCare (NYSEAMERICAN:NHCGet Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.74 earnings per share (EPS) for the quarter. National HealthCare had a net margin of 9.00% and a return on equity of 10.03%. The company had revenue of $408.03 million during the quarter.

National HealthCare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio (DPR) is currently 61.89%.

Insider Activity at National HealthCare

In related news, Director David R. Gifford sold 1,779 shares of National HealthCare stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $225.42, for a total transaction of $401,022.18. Following the transaction, the director owned 1,030 shares in the company, valued at approximately $232,182.60. This trade represents a 63.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the company’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total value of $355,620.00. Following the completion of the sale, the chief executive officer owned 65,487 shares of the company’s stock, valued at approximately $15,525,657.96. The trade was a 2.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 13.92% of the stock is currently owned by company insiders.

Analyst Ratings Changes

NHC has been the subject of several recent analyst reports. Royal Bank Of Canada upgraded National HealthCare to a “hold” rating in a research note on Monday, May 18th. BMO Capital Markets raised National HealthCare to a “hold” rating in a report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, Robert W. Baird raised National HealthCare to a “strong-buy” rating in a research note on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, National HealthCare has a consensus rating of “Buy”.

Check Out Our Latest Research Report on NHC

National HealthCare Profile

(Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Featured Articles

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHCFree Report).

Institutional Ownership by Quarter for National HealthCare (NYSEAMERICAN:NHC)

Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.